{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:39:06Z","timestamp":1792089546803,"version":"4.4.0"},"reference-count":71,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To assess the safety of buprenorphine compared with methadone to treat pregnant women with opioid use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase and the Cochrane Library from inception to February 2015 for randomized controlled trials (RCT) and observational cohort studies (OBS) that compared buprenorphine with methadone for treating opioid\u2010dependent pregnant women. Two reviewers assessed independently the titles and abstracts of all search results and full texts of potentially eligible studies reporting original data for maternal\/fetal\/infant death, preterm birth, fetal growth outcomes, fetal\/congenital anomalies, fetal\/child neurodevelopment and\/or maternal adverse events. We ascertained each study's risk of bias using validated instruments and assessed the strength of evidence for each outcome using established methods. We computed effect sizes using random\u2010effects models for each outcome with two or more studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Three RCTs (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0223) and 15 cohort OBSs (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a01923) met inclusion criteria. In meta\u2010analyses using unadjusted data and methadone as comparator, buprenorphine was associated with lower risk of preterm birth [RCT risk ratio (RR)\u2009=\u20090.40, 95% confidence interval (CI)\u2009=\u20090.18, 0.91; OBS RR\u2009=\u20090.67, 95% CI\u2009=\u20090.50, 0.90], greater birth weight [RCT weighted mean difference (WMD)\u2009=\u2009277\u2009g, 95% CI\u2009=\u2009104, 450; OBS WMD\u2009=\u2009265\u2009g, 95% CI\u2009=\u2009196, 335] and larger head circumference [RCT WMD\u2009=\u20090.90\u2009cm, 95% CI\u2009=\u20090.14, 1.66; OBS WMD\u2009=\u20090.68\u2009cm, 95% CI\u2009=\u20090.41, 0.94]. No treatment differences were observed for spontaneous fetal death, fetal\/congenital anomalies and other fetal growth measures, although the power to detect such differences may be inadequate due to small sample sizes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Moderately strong evidence indicates lower risk of preterm birth, greater birth weight and larger head circumference with buprenorphine treatment of maternal opioid use disorder during pregnancy compared with methadone treatment, and no greater harms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.13462","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T19:25:45Z","timestamp":1464204345000},"page":"2115-2128","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":220,"title":["Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta\u2010analysis of safety in the mother, fetus and child"],"prefix":"10.1111","volume":"111","author":[{"given":"Barbara K.","family":"Zedler","sequence":"first","affiliation":[{"name":"Venebio Group, LLC  Richmond Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Mann","sequence":"additional","affiliation":[{"name":"Venebio Group, LLC  Richmond Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi M.","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Biobehavioral Health Disparities Research, Division of Community Health Duke University  Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halle R.","family":"Amick","sequence":"additional","affiliation":[{"name":"Venebio Group, LLC  Richmond Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Joyce","sequence":"additional","affiliation":[{"name":"Venebio Group, LLC  Richmond Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Lenn","family":"Murrelle","sequence":"additional","affiliation":[{"name":"Venebio Group, LLC  Richmond Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"additional","affiliation":[{"name":"UNC Horizons, Department of Obstetrics and Gynecology, School of Medicine University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine Johns Hopkins University  Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA).Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville MD: SAMHSA 2011 Contract No.: HHS Publication no. (SMA) 11\u20134658."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.09.19142-en"},{"key":"e_1_2_8_5_1","first-page":"277","article-title":"Residential therapeutic communities for female substance abusers","volume":"67","author":"De Leon G.","year":"1991","journal-title":"Bull NY Acad Med"},{"key":"e_1_2_8_6_1","unstructured":"World Health Organization (WHO).Guidelines for identification and management of substance use and substance use disorders in pregnancy 2014. Available at:http:\/\/www.who.int\/substance_abuse\/publications\/pregnancy_guidelines\/en\/(accessed 1 September 2015) (Archived by WebCite\u00ae athttp:\/\/www.webcitation.org\/6gOmIM2FB)."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(75)90613-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00312-3"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00035-7"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2012.03.008"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318256496e"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/11632820-000000000-00000"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/npy.11.74"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02283.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2275"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8545(05)70362-4"},{"key":"e_1_2_8_17_1","unstructured":"World Health Organization (WHO).Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: WHO;2009."},{"key":"e_1_2_8_18_1","first-page":"347","article-title":"Methadone maintenance treatment (MMT): a review of historical and clinical issues","volume":"67","author":"Joseph H.","year":"2000","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.001"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006318.pub3"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","volume-title":"Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions","author":"Viswanathan M.","DOI":"10.23970\/AHRQEPCMETHGUIDE2"},{"key":"e_1_2_8_26_1","unstructured":"GuyattG. BusseJ.Methods Commentary: Risk of Bias in Cohort Studies: Evidence Partners; 2015. Available at:https:\/\/distillercer.com\/resources\/methodological\u2010resources\/risk\u2010of\u2010bias\u2010in\u2010cohort\u2010studies\/(accessed 10 September 2015) (Archived athttp:\/\/www.webcitation.org\/6gOpc4uqjon 1 September 2015)."},{"key":"e_1_2_8_27_1","unstructured":"WellsG. SheaB. O'ConnellD. PetersonJ. WelchV. LososM. et al.The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analyses. Available at:http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp(accessed 1 September 2015) (Archived athttp:\/\/www.webcitation.org\/6gOpODPiP)."},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_8_29_1","first-page":"2011","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins J."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-15"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.03.017"},{"key":"e_1_2_8_32_1","unstructured":"WestS. GartlehnerG. MansfieldA. PooleC. TantE. LenfesteyN.et al.Comparative Effectiveness Review Methods: Clinical Heterogeneity. Methods Research Paper (AHRQ Publication No 10\u2010EHC070\u2010EF) (internet).2010. Available at:http:\/\/effectivehealthcare.ahrq.gov\/(accessed 1 September 2015) (Archived athttp:\/\/www.webcitation.org\/6gOoAtvlc)."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7304.101"},{"key":"e_1_2_8_34_1","unstructured":"BerkmanN. D. LohrK. N. AnsariM. McDonaghM. BalkE. WhitlockE.et al.Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update Methods Guide for Comparative Effectiveness Reviews (internet).2013; AHRQ Publication No. 13(14)\u2010EHC130\u2010EF. Available at:http:\/\/effectivehealthcare.ahrq.gov\/ehc\/products\/457\/1752\/methods\u2010guidance\u2010grading\u2010evidence\u2010131118.pdf(accessed 1 September 2015) (Archived athttp:\/\/www.webcitation.org\/6gOn0I4Tx)."},{"key":"e_1_2_8_35_1","first-page":"87","article-title":"Follow\u2010up of pregnancies exposed to buprenorphine maintenance treatment","volume":"25","author":"Basselin C.","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"e_1_2_8_36_1","first-page":"80","article-title":"Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department","volume":"29","author":"Binder T.","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2007.05.017"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9176-1"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e31826b299d"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.025"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366018"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1049-9"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1224"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000092"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.10.629"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-19054"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.09.33335"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-821005"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.001"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2009.09.001"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2010.09.003"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04037.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04042.x"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.12.005"},{"key":"e_1_2_8_55_1","unstructured":"MartinJ.Pregnancy and Buprenorphine Treatment. Providers' Clinical Support System for Medication Assisted Treatment 2014. Available at:http:\/\/pcssmat.org\/opioid\u2010resources\/clinical\u2010tools\/(accessed 27 March 2016) (Archived athttp:\/\/www.webcitation.org\/6gQTmOQHT)."},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8624.1996.tb01874.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511777851"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62310-0"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3782(77)90017-2"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb13386.x"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511777851.003"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01193.x"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474108.3.6.719"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0913"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2011.553591"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089109053183"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02549.x"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-009-9465-9"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00009"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.06.007"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7125.140"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.027"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13462","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.13462","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.13462","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.13462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:12:26Z","timestamp":1780974746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.13462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1111\/add.13462"],"URL":"https:\/\/doi.org\/10.1111\/add.13462","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]},"assertion":[{"value":"2015-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}